Abstract
Endocrine therapy is the main treatment of hormone receptor-positive advanced breast cancer. How to reverse the endocrine resistance and the new endocrine therapy have become the focus of attention in the tumor community. The study of cyclin dependent kinase (CDKs) has developed rapidly, and the selective cdk4/6 inhibitors can significantly extend the progression-free survival of patients with endocrine resistance to breast cancer, which has been approved for standard treatment for advanced breast cancer. Key words: Advanced breast cancer; Endocrine therapy; American Society of Clinical Oncology (ASCO)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
